forteo solution
eli lilly canada inc - teriparatide - solution - 250mcg - teriparatide 250mcg - parathyroid agents
terrosa teriparatide (rbe) 250 microgram/ml solution for injection cartridge in a pre-filled pen
gedeon richter australia pty ltd - teriparatide, quantity: 250 microgram/ml - injection, solution - excipient ingredients: metacresol; water for injections; sodium hydroxide; hydrochloric acid; glacial acetic acid; mannitol; sodium acetate trihydrate - terrosa is indicated for the treatment of osteoporosis in postmenopausal women and the treatment of primary osteoporosis in men when other agents are considered unsuitable and when there is a high risk of fractures.,terrosa is indicated for the treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at high risk for fracture.
teriparatid-ratiopharm 20 mikrogramm/80 mikroliter injektionslösung
teriparatid heumann 20 mikrogramm/80 mikroliter injektionslösung im fertigpen
teriparatid welding 20 mikrogramm/80 mikroliter injektionslösung im fertigpen
teriparatid aristo 20 mikrogramm/80 mikroliter lnjektionslösung im fertigpen
teriparatid welding 20 mikrogramm/80 mikroliter injektionslösung im fertigpen
teriparatid alvogen 20 mikrogramm/80 mikroliter injektionslösung im fertigpen
teriparatid bcn peptides 20 mikrogramm/80 mikroliter injektionslösung im fertigpen
teriparatid biogaran 20 mikrogramm/80 mikroliter injektionslösung im fertigpen